Physician profile
David Barba
NPI 1205064722
$2,841.13
in general payments reported to CMS, 2019-2025
8 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $176 · 2021: $221 · 2022: $419 · 2023: $177 · 2024: $1,522 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084 · Travel and Lodging: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.03 |
| Travel and Lodging | $832.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,312.96 | 2020-2025 | Mako, Triathlon, Gamma |
| Medacta USA, INC. | $1,229.62 | 2024 | |
| Zynex Medical, INC. | $143.33 | 2025 | Nexwave |
| Camber Spine Technologies LLC | $83.19 | 2019 | |
| Ermi LLC | $26.72 | 2019-2020 | |
| Glaxosmithkline, LLC. | $17.84 | 2023 | Arexvy, Shingrix |
| Depuy Synthes Sales INC. | $14.07 | 2023 | Orthovisc |
| Amniox Medical, INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.